For this purpose, we determined the expression of the levels of Bcl2, Bax, and PCNA and the ratio of phospho-AKT/AKT, LDH-A, and VEGF in the tumor lysates, as shown in Figure 7A. Figure 7B shows the quantitative results that PCNA and the ratio of phospho-AKT/AKT, LDH-A, and VEGF were decreased in the tumor lysates of clone #92. The gene discussed is AKT1; the disease is neoplasm.